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ABSTRACT  
Post-transcriptional RNA modifications play an important role in cellular metabolism with homeostatic 
disturbances manifesting as a wide repertoire of phenotypes, reduced stress tolerance and 
translational perturbation, developmental defects, and diseases, such as type II diabetes, leukemia 
and carcinomas. Hence, there has been an intense effort to develop various methods for investigating 
RNA modifications and their roles in various organisms, including sequencing-based approaches and, 
more frequently, liquid chromatography mass spectrometry (LC-MS)-based methods. Although LC-
MS offers numerous advantages, such as being highly sensitive and quantitative over a broad 
detection range, some stationary phase chemistries struggle to resolve positional isomers. 
Furthermore, the demand for detailed analyses of complex biological samples often necessitates long 
separation times, hampering sample-to-sample turnover and making multisample analyses time 
consuming. To overcome this limitation, we have developed an ultra-performance LC-MS (UPLC-MS) 
method that uses an octadecyl carbon chain (C18)-bonded silica matrix for the efficient separation of 
50 modified ribonucleosides, including positional isomers, in a single 9 min sample-to-sample run. To 
validate the performance and versatility of our method, we analyzed tRNA modification patterns of 
representative microorganisms from each domain of life, namely Archaea (Methanosarcina 
acetivorans), Bacteria (Pseudomonas syringae) and Eukarya (Saccharomyces cerevisiae). 
Additionally, our method is flexible and readily applicable for detection and relative quantification 
using stable isotope labelling and targeted approaches like multiple reaction monitoring (MRM). In 
conclusion, this method represents a fast and robust tool for broad-range exploration and 
quantification of ribonucleosides, facilitating future homeostasis studies of RNA modification in 
complex biological samples. 
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INTRODUCTION 
During the past decade, research into post-transcriptional nucleoside modifications – in particular 
those of messenger RNA and transfer RNA – has experienced a renaissance as their multifaceted 
roles, ranging from translational control1 via infection2 and stress response3,4 to development and 
aging5,6, are slowly beginning to unfold. This can be credited to methods and instrument development 
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in two key areas; (I) translation studies using ribosome profiling combined with next-generation 
sequencing7,8, which enables detailed insights into the translational state of cells, and (II) identification 
and quantitative characterization of modified ribonucleosides by liquid chromatography mass 
spectrometry (LC-MS). In case of the latter, advances in instrument design, such as improved mass 
resolution and accuracy, sensitivity, dynamic range, and scan speed, coupled with improved 
stationary phase chemistries, has expanded the applicability of LC-MS based ribonucleoside 
modification analysis. However, to achieve a robust and reliable analysis platform with minimal bias, 
careful consideration must be given to the choice of mobile and stationary phase as well as the 
solvent delivery system. Currently, reversed-phase high performance liquid chromatography (RP-
HPLC) using C18-based materials coupled with electrospray ionization mass spectrometry (ESI-MS) 
is the prevailing approach used by numerous laboratories4,9–20. In addition, bespoke methods have 
been developed using other stationary phases, such as HILIC21,22 and porous graphitic carbon 
(PGC)23,24. 
Despite these recent advances, existing HPLC-MS methods are often relatively lengthy as they 
necessitate separation times ranging from 15 to >70 min, followed by a regeneration step of 5 to 20 
min. Consequently, the total sample-to-sample turnover time can be in excess of 90 min, thereby 
reducing their applicability for analysis of large sample cohorts. To overcome this limitation, several 
ultra-performance LC-MS (UPLC-MS) methods have been established to accelerate ribonucleoside 
analyses by reducing overall run times16,19,22,25. Nonetheless, these approaches were employed to 
analyze only a limited number of ribonucleosides. This also restricts their applicability for 
ribonucleoside analysis as different types of RNA molecules have a significant variability in their 
modification composition. Therefore, a method suitable for the detection of multiple modifications, 
especially positional isomers, is desirable. Such an universal method, easily applicable to any 
organism and type of RNA, would undoubtedly provide a powerful tool for investigation of the 
crosstalk between the modifications in different RNA molecules26, as well as their conservation across 
the species.  
To this end, we initially compared the suitability of three distinct UPLC-compatible stationary 
phases for broad-range applicability and unbiased separation of modified ribonucleosides. Using a 
BEH-C18 column, we developed a fast and robust UPLC-MS approach for accurate and quantitative 
identification of 50 ribonucleosides during a single 9 min analysis run (5 min separation and 4 min 
column wash and equilibration). Furthermore, we have validated our method by analyzing a complex 
mix of synthetic standards and biological RNA isolates originating from representative 
microorganisms of all three domains of life (Archaea, Bacteria and Eukarya). Compared to currently 
available protocols, the method presented here provides a reduced total runtime and an improved 
separation of isobaric ribonucleosides, such as positional isomers, which together with unique 
fingerprint ionization patterns ensures their reliable identification. Taken together, this UPLC-MS 
method represents a versatile and easily implementable tool for reproducible and reliable 
ribonucleoside quantification that is readily applicable for large sample cohorts. 
MATERIAL AND METHODS 
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Chemicals and ribonucleoside standards 
The chemicals used were, unless otherwise stated, purchased from Acros Chemicals and/or 
Fisher Chemicals in the highest purity level available. The ribonucleoside standards were purchased 
from Carbosynth (Newbury, UK), Sigma-Aldrich (canonical ribonucleosides only), and BOC Sciences 
(m2A only), including 50 naturally occurring ribonucleosides (full names are in Supplementary Table 
S1): A, C, G, U, Ψ, Am, Cm, Gm, Um, I, Im, m1I, m1A, m2A, m6A, m8A, m2,8A, ms2m6A, m6Am, ac6A, f5C, 
m3C, m4C, m5C, m4Cm, m5Cm, hm5C, m4,4C, ac4C, ac4Cm, m1G, m2G, m7G, m2,2G, m2,7G, imG-14, m3U, 
ncm5U, m5U, m5s2U, mcm5U, mcm5s2U, cnm5U, mo5U, cm5U, ho5U, s2C, s2U, s4U, m1Ψ, and 1 non-
natural ribonucleoside - m1,3Ψ. The purity of each standard is noted in Supplementary Table S1. 
Preparation of standards 
Ribonucleoside standards were dissolved in 5 mM ammonium formate (NH4HCO2), pH 5.3 to 
concentration of 50 μg/ml. A limited (LM) and complete mix (CM) containing 22 and 50 ribonucleoside 
standards, respectively, were mixed at concentration of 10 μg/ml. To differentiate the isomeric 
ribonucleoside modifications, four different mixes (M1-M4) were prepared at final concentration 10 
μg/ml. The detailed composition of these mixes is specified in the Supplementary Data 
(Supplementary Tables S1-S5). 
Biological material, transfer RNA isolation and its preparation for C18-UPLC-MS analysis 
Saccharomyces cerevisiae BY4741 and Pseudomonas syringae pv. tomato DC3000 were grown 
at 28 °C, 180 rpm in 100 ml YPD and King’s B medium, respectively. Cells were harvested by 
centrifugation at 4 000 g, 4 °C, 5 min. Methanosarcina acetivorans C2A Δhpt27 was cultivated 
anaerobically at 37 °C, in a single-cell morphology28 in 50 ml of high-salt broth medium containing 125 
mM methanol (detailed composition in Supplementary Methods). Cultures were harvested 
anaerobically by centrifugation. The collection time points (t1 and t2, respectively) were as follows: 1 h 
and 6 h for S. cerevisiae; 1 h and 4 h for P. syringae; and 8 h and 27 h for M. acetivorans.  
The 15N metabolically labelled RNA was prepared by growing P. syringae in M9 minimal medium 
supplemented with 15NH4Cl (Sigma-Aldrich) as the only nitrogen source. Cells were grown O/N and 
then used for inoculation of new culture. Subsequently, the cells were cultivated until logarithmic 
growth phase and then were harvested as described above. tRNA was isolated as described below 
and the labelling efficiency was estimated by MS (data not shown).  
Purification of tRNA from S. cerevisiae was performed as previously described18 with minor 
changes for P. syringae and M. acetivorans. Briefly, total RNA was isolated using TRI reagent 
(Invitrogen) according to manufacturer’s protocol. The RNA containing aqueous phase was then 
transferred to a fresh centrifugation tube and re-isolated by addition of 2 ml acidic phenol and 0.1 vol. 
of 1-bromo-3-chloropropane (BCP). The suspension was vortexed for 1 min and centrifuged for 15 
min at 10 000 g. The RNA containing aqueous phase was collected and the volume was adjusted to 
10 ml with equilibration buffer EQ (10 mM Tris-HCl, pH 6.3, 15% ethanol, 200 mM KCl), following 
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which it was applied onto a pre-equilibrated (EQ buffer containing 0.15% Triton X-100) Nucleobond 
AX-100 column (Macherey-Nagel). The column-bound RNA was washed twice with wash buffer WB 
(10 mM Tris-HCl, pH 6.3, 15% ethanol, 300 mM KCl), and the tRNA containing fraction was eluted 
with warm (55 °C) elution buffer EB (10 mM Tris-HCl, pH 6.3, 15% ethanol, 750-800 mM KCl) into 2.5 
vol. of 99.6% ethanol. The tRNA was precipitated O/N at -20 °C and pelleted by centrifugation at 10 
000 g, 4 °C for 30 min. Residual salt was washed out with 80% ethanol. The final tRNA pellet was air-
dried at room temperature and re-suspended in RNase/DNase-free water. The quality and purity of 
isolated tRNA was assessed by denaturing electrophoresis on 10% polyacrylamide gel 
(Supplementary Data). Dephosphorylated mononucleosides for MS analysis were generated as 
previously described23. Prior to MS analysis, the completeness of cleavage was verified by gel 
electrophoresis. For data normalization, P. syringae nucleosides were mixed with 15N-labeled 
ribonucleosides, which served as internal standard (25 ng 15N-labeled ribonucleosides per 100 ng of 
sample).  
UPLC-MS using BEH C18 columns 
Unless otherwise stated, all ribonucleoside standards and biological samples were analyzed with 
Waters Acquity® UPLC system (Waters, Milford MA, USA) attached to Waters Synapt G2 HDMS 
mass spectrometer (Waters, Milford MA, USA) via an ESI ion source. All samples were analyzed in 
positive ion mode (sensitivity) with the mass range (m/z) from 100 to 600. The samples were loaded 
onto the column as follows: single ribonucleoside standards or their mixes, 50 ng; and 
dephosphorylated mononucleosides originating from biological material, 500 ng. Ribonucleoside 
separation was performed in Acquity UPLC® Ethylene Bridged Hybrid [BEH] C18 columns (1.7 μm, 
2.1 × 50 and 150 mm, Waters, Ireland) at +40 °C. The mobile phase consisted of (A) 0.1% formic acid 
in MQ H2O (Merck Millipore, Bedford, MA, USA) and (B) 0.1% formic acid in acetonitrile (Honeywell, 
Riedel-de Haën, CHROMASOLV™, LC-MS grade, Steinheim, Germany). Ribonucleoside separation 
was achieved by a two-step gradient ranging from 1-12% B for 3 min and 12-70% B for another 3 min, 
followed by a shift to 1% B and subsequent equilibration step for 3 min, with a total run time of 9 min. 
The flow rate of the mobile phase was 0.45 ml/min, the injection volume was 10 μl and tray 
temperature was set to 15 °C. Capillary voltage was set to at 3.0 kV, sampling cone 30 and extraction 
cone 3.0, the source temperature 120 °C and desolvation temperature 400 °C, cone and desolvation 
gas flow rate was set to 20 l/h and 800 l/h, respectively. Detailed steps of UPLC-MS method 
development, including ribonucleoside separation on other stationary phases and optimization of 
ionization parameters are outlined in Supplementary Methods. Parameters used for multiple reaction 
monitoring (MRM) with AB Sciex UPLC-MS QTRAP-6500+ instrument are described in 
Supplementary Methods and Supplementary Table S7. 
Data analysis  
Total ion (TIC) and extracted ion (XIC) chromatograms were generated from .RAW format using 
MZmine2 software (version 2.40.1)29 and exported in csv format. Peak identification was performed 
by custom database identification module of MZmine2 using a lookup list of ribonucleosides 
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consisting of previously reported [M+H]+ and product ions masses (data from Modomics30); and the 
retention time information acquired from analyzing available standards. Based on the data obtained 
with our instrument, this list was further manually curated and additional ions detected in standards 
and biological samples were added (Figure 2C and Supplementary Figures S3, S6). The final identity 
assignment was confirmed only when both, [M+H]+ and product ions were detected in MS1 spectrum. 
For data visualization, the relative signal intensities were calculated as a proportion of the most 
intense signal in the spectrum. To quantify the changes in ribonucleoside modifications, the absolute 
intensities were first normalized to cytidine and/or to equivalent 15N-labeled ribonucleoside (where 
applicable) to reflect the variances in amount of input tRNA31. Subsequently, the relative changes are 
represented as t2/t1 ratio of normalized intensities. Error bars in plots represent standard deviations of 
three independent replicates and p-values were calculated by one-sample Student’s t-test. The data 
visualization and calculations were done by custom scripts in R (version 3.6.3) using tidyverse 
package (version 1.3.0)32. The calculation of chromatographic parameters for the C18 column is 
outlined in the Supplementary Methods. 
 
RESULTS 
C18 UPLC enables short run times and favorable separation and identification of multiple 
modified ribonucleosides in a single analysis 
Ribonucleosides are highly polar compounds and notoriously difficult to analyze on most 
stationary phases33. Hence, we first investigated the elution characteristics of 22 ribonucleosides (LM) 
on three stationary phases, which are most frequently used for ribonucleoside analysis4,9,13–16,21–23,34 – 
hydrophilic interaction chromatography (HILIC), carbamoyl-coated silica (Amide), and octadecyl 
carbon chain (C18)-bonded silica – using normal or reversed phase UPLC-compatible setups in 50 or 
100 mm column format (Supplementary Figure S1). The initial experiments using our UPLC-MS 
conditions showed that separation of LM standards on BEH-HILIC and BEH-AMIDE columns (both 
100 mm long) was insufficient, especially for the positional isomers. Additionally, we also observed 
substantial peak tailing and unsatisfactory signal-to-noise ratios (Supplementary Figure S1A-D). On 
the other hand, the 50 mm BEH-C18 column was able to achieve the fastest separation time (<3 min), 
while providing more favorable signal-to-noise ratios and an exceptional separation for all tested 
ribonucleosides, including positional isomers (Supplementary Figure S1E). Thus, we continued the 
method development using only this stationary phase.  
To obtain a method by which multiple modified ribonucleosides can be identified in a single 
analysis, we increased the number of ribonucleoside standards to 50 (see Experimental section) and 
assessed their individual elution and ionization characteristics (Supplementary Figure S2 and S3), as 
well as their chromatographic parameters (Supplementary Table S6). Next, we decided to increase 
the challenge by analyzing these 50 standards in a complex mix (CM) using our UPLC-MS coupled to 
the BEH-C18 column. However, the 50 mm BEH-C18 column proved inadequate for reliable 
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identification of all the CM standards (data not shown). Therefore, we examined the CM separation on 
a longer 150 mm column with the same BEH-C18 stationary phase (Figure 1A). To facilitate the 
identification of all available isomers, we prepared four mixes of standards (M1-4), where each mix 
contained only one of the available isobaric isomers (Figure 1B, Supplementary Figure S4). The 
examination of M1-4 XICs overlays showed that most isobaric isomers achieve baseline separation 
(Figure 1C, Supplementary Figure S5A). Nevertheless, some positional isomers including methylated 
cytidines, methylated inosines, and methylated guanosines, eluted too closely to each other and 
prevented their differentiation solely by retention time (Figure 1C-D). Therefore, we closely re-
examined the individual spectra of these isomers (Supplementary Figure S3) and compared their 
fragmentation patterns. In the case of methylated inosines (Figure 1D, right panel), the spectral 
comparison provided a confident measure for isomer identification. Similarly, this approach also 
proved sufficient for distinction of Gm and m2G/m1G, which elute closely to each other (Supplementary 
Figure S5B). However, this approach was not applicable for distinguishing base methylated cytidines.  
The comparison of our recorded spectra to previously published data30 revealed an additional 
variation in fragmentation patterns (Supplementary Figure S3, in red), namely the addition of dimer 
ions ([2M+H]+). Dimerization occurs in the ESI chamber and is influenced by the LC-conditions (pH, 
solvents) and ES ionization parameters (voltage, temperature etc.), as well as the chemical properties 
and concentration of the analytes. Since the analysis conditions constitute the best possible 
compromise for all 50 analytes, dimer formation (Supplementary Figure S3) cannot be entirely 
avoided without experiencing a significant reduction in chromatographic resolution or ionization 
efficiency. In the case of specific analytes, we observed dimers in the ribonucleoside standards 
throughout a wide concentration range as well as in the biological samples. This dimerization pattern 
proved beneficial in assigning the identity of co-eluting positional isomers. For example, the spectra of 
methylated cytidines m4C, m5C and Cm contains an ion at m/z 515, whereas this ion is absent in m3C 
(Supplementary Figure S5C). Indeed, it has been recently shown that N3 methylation, which is 
present on the Watson-Crick face of m3C, significantly weakens the base pairing propensity of 
cytidine35, which suggests that steric hindrance may prevent m3C dimer (m/z 515) formation. 
Furthermore, similar fingerprint ionization patterns for distinction of isomers has been characterized 
before using higher-energy collisional dissociation MS36.  
C18 UPLC-MS provides robust identification of ribonucleosides in biological samples from 
various organisms 
While CM standards resemble the complexity of biological samples, the RNA isolates often 
contain impurities that may impair MS analysis. Transfer RNA (tRNA) contains on average 13 
ribonucleoside modifications per molecule, although the exact number and type of modifications vary 
between different organisms and tissue types or due to growth conditions and/or presence of 
stress3,4,8,30,37. To determine if our method can robustly identify and quantitatively characterize relative 
modification changes, we decided to analyze ribonucleoside modifications in total tRNA of three 
representative microorganisms – M. acetivorans (Archaea), P. syringae (Bacteria) and S. cerevisiae 
(Eukarya) (Figure 2A, Supplementary Figure S6). In agreement with previously published data30,38, we 
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detected a total of 32 tRNA modifications, including anticodon modifications, such as mcm5U34, 
mcm5s2U34 and m1I37 in Eukarya39–41 and s2C32 in Bacteria42 (Figure 2B). Next, we compared the 
detected modifications between the organisms included in the study, highlighting the presence of both 
universal and specific modifications, which are present only in a particular domain of life. For example, 
s2C and m3U can be found only in Bacteria, whereas imG-14 is an archaeal modification; mcm5U, 
mcm5s2U, and m1I are eukaryotic modifications, and m1G, m2G, m6A, Ψ, Cm are universally conserved 
throughout all organisms (Figure 2B). On the other hand, rRNA-specific modifications30,38, such as 
m8A, m2,8A, and m4C, were not observed, indicating a sufficient purity of our tRNA isolates 
(Supplementary Figure S6A). Upon a detailed analysis of the data, we observed additional peaks that 
were unassigned, as they did not match any of the available standards. To identify these peaks, we 
created a custom lookup list, which allowed identification by matching their spectra with published 
data30. The confidence of identification was further increased by considering only those modifications 
for which all previously published ions were detected. Using this approach and the known presence of 
particular modifications in tRNAs across domains of life, we were able to identify the following 
modifications: archaeosine (G+), agmatidine (C+) in Archaea; epoxyqueuosine (oQ), 2-
methyladenosine (m2A) and N6-(cis-hydroxyisopentenyl) adenosine (io6A) in Bacteria; N6-
isopentenyladenosine (i6A) in Bacteria and Eukarya, and N6-threonyl-carbamoyladenosine (t6A) in all 
organisms30,43,44 (Figure 2B-C, Supplementary Figure S6B and S6C). As for the unassigned fifth 
methylated adenosine peak, we utilized the retention times of the known positional isomers (Am, m8A, 
m1A and m6A), spectral matching and its occurrence, which is limited to bacterial samples, to 
conclude that its identity is most likely that of m2A (Figure 2C). Therefore, we obtained a m2A 
standard and, based on retention time and mass spectrum comparison to the other methylated 
adenosines, we confirmed that the unassigned fifth methylated adenosine peak indeed corresponds 
to m2A (Figure 2D).  
High-resolution baseline separation of individual analytes requires high stability of the stationary 
phase over multiple analyses. To determine the suitability of the BEH-C18 column for large-scale 
studies, we analyzed the retention time variance for the canonical nucleosides throughout 80 
consecutive runs (Figure 3A-B). The observed shifts in retention times were negligible, achieving a 
mean variance of 0.05-0.06 min (Figure 3B), thus confirming the high reproducibility of the method 
and its suitability for studying large sample cohorts. 
Relative quantification of ribonucleosides by C18 UPLC-MS 
As cells grow, nutrients become increasingly scarce and potentially toxic metabolic byproducts 
become more abundant, creating an imbalance that causes nutritional stress. Biotic stress is reflected 
in tRNA modification levels as protein synthesis must adapt to maintain cellular homeostasis45–48. 
Therefore, quantifying tRNA modification changes provides insights that allow us to understand how 
protein synthesis is modulated by post-transcriptional modifications. To investigate the suitability of 
our method for such studies, we analyzed the changes in tRNA modification levels of cells harvested 
at the early exponential growth (t1) and late exponential growth phases (t2) in set of three independent 
replicates (n=3) (Figure 4).  
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First, we utilized internal normalization with metabolically labeled ribonucleosides17,23 by preparing 
a batch of [15N] stable isotope labeled tRNA of P. syringae and analyzing it as a spike-in mixture with 
non-labeled ribonucleosides (see Material and Methods). Our analysis showed that [15N]-labeled 
ribonucleosides can be easily detected for a majority of all ribonucleosides present in P. syringae 
(Supplementary Figure S7). This approach significantly improves the accuracy of relative 
quantification by eliminating the variance that stems from the differences in ribonucleoside ionization 
efficiency23. However, metabolic labeling is not without its limitations. To cover all ribonucleosides, 
spike-in batches must originate from the same organism as the non-labeled sample and, while this 
may be relatively straightforward and cost-efficient for microbes, it becomes a significant limiting factor 
for many other model organisms, not to mention tissues and clinical samples.    
Consequently, we decided to normalize the peak intensities to the cytidine signal to mitigate intra-
sample loading variances31. This approach also allowed a comparison of the relative modification 
changes between all tested organisms (Figure 4). Unsurprisingly, we observed significant changes in 
abundance for several anticodon stem loop modifications, such as i6A, t6A, mcm5U, mcm5s2U, and 
ncm5U (Figure 4, grey panels). These modifications alter the processivity and fidelity of translation 
and for example, mcm5s2U34 has been shown to be critical for the efficient translation of certain 
stress-induced gene transcripts20,49,50. By optimizing conditions for multiple reaction monitoring mode 
(MRM) with QQQ detector (parameters in Supplementary Table S7), we further increased the 
detection sensitivity and observed modifications, such as ac6A, cm5U, that could otherwise not be 
detected using the QTOF detector (Supplementary Figure S8). Consequently, our C18 UPLC-MS 
approach offers a flexible method suitable for broad range or targeted characterization and relative 
quantification of tRNA modifications and their changes in response to environmental conditions.  
DISCUSSION 
Here, we present an improved and fast UPLC-MS method for the simultaneous identification of 50 
ribonucleosides. Thanks to the utilization of UPLC separation on BEH-C18 column, we achieved short 
ribonucleoside separation (<5 min) and column regeneration times, resulting in a total analysis time of 
only 9 minutes. This approach provides reproducible and reliable relative quantification of global 
nucleoside modification changes in various organisms. Furthermore, we also show that our method is 
directly compatible with previously published spike-in [15N] stable isotope labeling techniques for 
signal normalization17,23, which further increase the quantification accuracy. This UPLC-MS method 
can also be used for dynamic monitoring of tRNA modification changes via pulse-chase labelling 
approaches, such as NAIL-MS16. 
In this study, we have validated our method using nucleoside standards (Figure 1) and tRNA 
(Figure 2), which features the highest diversity of post-transcriptional nucleoside modification of any 
RNA species. Importantly, our method highly flexible and due to the number of identified modifications, 
it can be easily implemented for the complete modification, i.e. ‘modificome’, analysis of other RNA 
species, such as ribosomal RNA and messenger RNA. However, due to a significantly lower 
proportion of modified ribonucleosides in these RNA species, the use of more sensitive MS detectors, 
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such as QQQ, or enrichment of target molecules prior analysis might be necessary. In addition, we 
have shown that in some cases nucleoside modifications can be identified and quantified even 
without standards by matching the ionization profiles to previously published data. Nevertheless, the 
lack of standards does limit the applicability of the method for absolute quantification, as this 
necessitates the use of ribonucleoside-specific calibration curves for the instrument. Future 
developments will focus on analyzing additional standards and utilizing tandem mass spectrometry to 
confirm the identity of those modifications, for which standards are currently unavailable. In 
conclusion, our UPLC-MS method constitutes the first robust and universally applicable tool for fast 
detection and quantification of RNA modifications in complex biological samples.  
SUPPLEMENTARY DATA 
Supplementary data for this article are available online. 
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TABLE AND FIGURES LEGENDS 
Figure 1. C18 UPLC-MS provides baseline separation of 50 ribonucleosides and enables their 
reliable identification. (A) Total ion chromatogram (TIC) of CM of standards analyzed on 150 mm C18 
column and (B) overlaid TICs of M1-M4. (C) The separation of selected isobaric and positional 
isomers on 150 mm C18 column represented as extracted ion chromatograms (XICs extracted from 
C18 UPLC-MS analysis of M1-M4. (D) XICs of selected positional isomers (left panel) and their 
respective MS spectra (right panel) showing the distinct ionization profile. 
Figure 2. Analysis of tRNA modifications in representative microorganisms of each kingdom of life. (A) 
Individual TICs of archaeal (M. acetivorans), bacterial (P. syringae) and eukaryotic (S. cerevisiae) 
14 
modifications and their overlay showing the variability of tRNA modifications across kingdoms of life. 
Zoomed section displays the differences in modifications present in each organism and modifications 
identified without standards are in blue. (B) Summary of detected modifications in each 
microorganism. Modifications identified without standards are in blue. (C) Identification of unknown 
peaks present in biological samples. Overlay of XICs across all three organisms (left panel) and their 
respective mass spectra (right panel) highlighting the unique ionization profiles. Arrows in spectra 
point to neutral loss ions. In XICs, the peak of interest is marked by *. (D) Confirmation of m2A identity 
by XIC analysis of the m2A standard alone (top panel) or in a mixture (middle panel) with all five 
naturally occurring methylated adenosines (m1A, m2A, m6A, m8A, Am). The retention time and mass 
spectrum of the m2A standard (top panel) corresponds to that of the previously unassigned peak 
(marked by *) in the bacterial (P. syringae) sample (bottom panel).  
Figure 3. C18 UPLC-MS provides robust and reproducible quantification of modified ribonucleosides. 
(A) Three representative samples selected from consecutive runs showing the XICs of the canonical 
ribonucleosides. (B) Retention time variability over multiple runs. Rt represents retention time at apex 
of each peak, std equals standard deviation and ΔRt(mean) is the mean difference between the start 
and the end of peak. 
Figure 4. Relative quantification of tRNA modification changes between early exponential growth (t1) 
and late exponential growth phases (t2). S.c. - S. cerevisiae, P.s. - P. syringae, M.a. - M. acetivorans. 
Panels in grey show anticodon stem loop modifications. Grey line highlights value 1 (no change). 
Statistical significance was calculated using one-sample Student’s t-test and * shows values with p < 
0.05 (n = 3). 
